Elsevier Poised to Enter Business Intelligence Market

Publisher Developing Suite of Solutions for Pharmaceutical and Biotech Researchers

Amsterdam, 31 October 2005 - Elsevier, a world-leading healthcare and scientific publisher, announced today that it is developing a suite of business intelligence solutions for the pharmaceutical and biotech market. To meet the demanding requirements of business intelligence, market research and business development professionals, Elsevier is developing customizable, integrated products that will provide the information they need to make informed business decisions.

Working in cooperation with AdvantTechnologies (aTi), Elsevier is developing a suite of business intelligence solutions to include a database of drugs in clinical development, consulting and syndicated reports. The database will be launched to the market in early 2006.

"Our position as a leading publisher of quality, peer-reviewed content and our key opinion leader network, coupled with aTi's technology means we can deliver business intelligence solutions pharmaceutical and biotech professionals can trust," says Brian Nairn, CEO of Elsevier, Health Sciences. "To ensure we deliver products that will give them confidence in the information they receive, we've solicited the input of a group of seasoned industry advisors and we're investing in extensive user testing."

Elsevier's business intelligence product development drive will be lead by newly appointed Director of Emerging Products, Julie Gordon. "We've conducted qualitative research with pharmaceutical and biotech professionals throughout North America, Europe and Japan. The respondents told us there's a demand for business intelligence solutions that are accurate, timely and focused," says Gordon, "We are developing a suite of products that are flexible and modular so that users can easily and efficiently mine the data they need, when they need it."

# # #

About AdvanTechnologies Inc.
Founded by world-renowned IT researchers, AdvanTechnologies (aTi) provides state-of-the-art Knowledge Management Enabling software products and associated decision support tools targeted to the pharmaceutical, biomedical and healthcare industries. For more information visit www.advantechnologies.com.

About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com

Media Contact:
Paula Reeves
The Reeves Agency
Tel. +31-(0)20-3051380